U.S. Attorney News Release: Albany Plastic Surgery Group Pleads Guilty in Connection With Use of Unlicensed "Botox" Substitute on Unsuspecting Patients
Tue, 11 Aug 2009 19:51:00 -0500
The Plastic Surgery Group, LLP (“TPSG”), of Albany, New York, pled guilty today to one felony count of misbranding drugs in connection with the use, on unsuspecting patients, of a cheaper “BOTOX” substitute that was not approved by the Food and Drug Administration. TPSG admitted that, with intent to mislead, it injected patients with Botulinum Toxin Type A manufactured by Toxin Research International, Inc. of Arizona ("TRI-toxin”) misbranded under the name of another drug, namely BOTOX/ BOTOX Cosmetic. Five physicians, the practice administrator, and the Supervisory Nurse of TPSG also pled guilty today, to strict-liability misdemeanor misbranding violations arising from the same conduct in 2004.
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
